Reversible schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor

Annals of Neurology

Volumn 41, Issue 1, 1997, Pages 82-93

  Winkler, Jürgen ^a,b   Ramirez, Gilbert A ^a,b   Kuhn, H Georg ^c   Peterson, Daniel A ^c   Day Lollini, Patricia A ^d   Stewart, Gregory R ^d   Tuszynski, Mark H ^a,b   Gage, Fred H ^c   Thal, Leon J ^c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d ROCHE BIOSCIENCE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FOREBRAIN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; RAT; SCHWANN CELL; SYMPATHETIC NERVE;

ANIMALS; HYPERPLASIA; INJECTIONS, INTRAVENTRICULAR; MALE; NERVE GROWTH FACTORS; NEURITES; RATS; RATS, INBRED F344; SCHWANN CELLS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0031037424     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410114     Document Type: Article

References (87)

1. Evans DA, Funkenstein H, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons. JAMA 1989;262:2551-2556
2. Lilienfeld DE, Perl DP. Projected neurodegenerative disease mortality in the United States, 1990-2040. Neuroepidemiology 1993;12:219-228
3. Katzman R. Alzheimer's disease. N Engl J Med 1986;314:964-973
4. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991;16:487-498
5. Whitehouse PJ, Price DL, Struble RG, et al. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-1239
6. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-417
7. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of central cholinergic innervation. Science 1983;219:1184-1190
8. Wilcock GK, Esiri MM, Bowen DM, et al. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with severity of dementia and histological abnormalities. J Neurol Sci 1982;57:407-417
9. Fibiger H. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci 1991;14:220-223
10. DeKosky ST, Harbourgh RE, Schmitt FA, et al. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann Neurol 1992;32:625-632
11. Lehericy S, Hirsch EC, Cervera-Pierot P, et al. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J Comp Neurol 1993;330:15-31
12. Thai LJ. Clinical trials in Alzheimer disease. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer disease. New York: Raven Press, 1994:431-444
13. Hefti F, Denton TL, Knusel B, et al. Neurotrophic factors: what are they and what are they doing? In: Loughlin SE, Fallon JH, eds. Neurotrophic factors. San Diego: Academic Press, 1993:25-49
14. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-1162
15. Thoenen H, Bandtlow C, Heumann R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem Pharmacol 1987;109:145-178
16. Hefti F, Hartikka J, Knusel B. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol Aging 1989;10:515-533
17. Chao MV, Bothwell MA, Ross H, et al. Gene transfer and molecular cloning of the human NGF receptor. Science 1986;232:518-521
18. Johnson D, Lanahan A, Buck CR, et al. Expression and structure of the human NGF receptor. Cell 1986;47:545-554
19. Kaplan DR, Hempstead BL, Martin-Zanca D, et al. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991;525:554-558
20. Kaplan DR, Martin-Zanca D, Parada LF. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 1991;350:158-160
21. Hempstead BL, Martin-Zanca D, Kaplan DR, et al. High affinity NGF binding requires coexpression of the trk protooncogene and the low-affinity NGF receptor. Nature 1991;350:678-682
22. Batchelor PE, Armstrong DM, Blaker SN, et al. Nerve growth factor receptor and choline acetyltransferase colocalization in neurons within the rat forebrain: response to fimbria-fornix transection. J Comp Neurol 1989;284:187-204
23. trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron 1992;9:465-478
24. Steininger TL, Wainer BH, Klein R, et al. High-affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult brain. Brain Res 1993;612:330-335
25. Gibbs RB, Pfaff DW. In situ hybridization detection of trkA mRNA in brain: distribution, colocalization with p75NGFR and up-regulation by nerve growth factor. J Comp Neurol 1994;341:324-339
26. Verdi JM, Birren SJ, Ibáñez CF, et al. p75LNGFR regulates trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron 1994;12:733-745
27. Smith G. Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Res Rev 1988;13:103-118
28. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transection. J Neurosci 1986;14:2155-2162
29. Kromer LF. Nerve growth factor treatment after brain injury prevents neuronal death. Science 1987;235:214-216
30. Williams LR, Varon S, Peterson G, et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transection. Proc Natl Acad Sci USA 1986;83:9231-9235
31. Tuszynski MH, U HS, Amaral DG, et al. Nerve growth factor infusion in primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci 1990;10:3604-3614
32. Koliatsos VE, Nauta HJW, Clatterbuck RE, et al. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J Neurosci 1990;10:3801-3813
33. Mandel RJ, Gage FH, Thal LJ. Spatial learning in rats: correlation with cortical choline acetyltransferase and improvement with NGF following NBM damage. Exp Neurol 1989;104:208-217
34. Dekker AJ, Gage FH, Thal LJ. Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: evaluation of different neurotransmitter systems. Neuroscience 1992;48:111-119
35. Hefti F, Dravid A, Hartikka JJ. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septohippocampal lesions. Brain Res 1984;293:305-311
36. Haroutunian V, Kanof PD, Davis KL Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor. Brain Res 1986;386:397-399
37. Dekker AJ, Thal LJ. Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: dose requirements. Brain Res 1992;584:55-63
38. Dekker AJ, Langdon DJ, Gage FH, et al. NGF increases cortical acetylcholine release in rats with lesions of the nucleus basalis. Neuroreport 1991;2:577-580
39. Rylett RJ, Goddard S, Schmidt BM, et al. Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer 344 rats. J Neurosci 1993;13:3956-3963
40. Fischer W, Wictorin K, Bjorklund A, et al. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987;329:65-68
41. Kordower JH, Gash DM, Bothwell M, et al. Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer's patients. Neurobiol Aging 1988;10:287-294
42. Mufson EJ, Bothwell M, Hersch LB, et al. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J Comp Neurol 1989;285:196-217
43. Hefti F, Lapchak PA. Pharmacology of nerve growth factor in the brain. Adv Pharmacol 1993;24:239-273
44. Venero JL, Hefti F. TrkA NGF receptor expression by non-cholinergic thalamic neurons. Neuroreport 1993;4:959-962
45. Holtzman DM, Kilbridge J, Li Y, et al. TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons. J Neurosci 1995;15:1567-1576
46. Winkler J, Thal LJ. Duration of biochemical effects of treatment with nerve growth factor in NBM-lesioned rats using quisqualic acid. Soc Neurosci Abstr 1994;20:442 (Abstract)
47. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York; Academic Press, 1986
48. Gibson SJ, Polak JM, Giaid A, et al. Calcitonin gene-related peptide messenger RNA is expressed in sensory neurones of the dorsal root ganglia and also in spinal motor neurons in man and rat. Neurosci Lett 1988;91:283-288
49. Vanhoutte PM, Shepherd JT. Autonomic nerves to the systemic blood vessels. In: Dyck PJ, Thomas PK, Griffin JW, et al, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1993:208-227
50. Day-Lollini PA, Stewart GR, Taylor MJ, et al. Hyperplastic changes within the leptomeninges of the rat and monkey in response to chronic intracerebroventricular infusion of nerve growth factor. Exp Neurol (in press)
51. 11C] nicotine binding, blood flow, EEG and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm 1992;4:79-95
52. Olson L, Backlund EO, Ebendal T, et al. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease; one-year follow-up of first clinical trial. Arch Neurol 1991;48:373-381
53. Olson L. NGF and the treatment of Alzheimer's disease. Exp Neurol 1993;124:5-15
54. Phelps CH, Gage FH, Growdon JH, et al. Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol Aging 1989;10:205-207
55. Menesini-Chen MG, Chen JS, Levi-Montalcini R, Sympathetic nerve fibers ingrowth in the central nervous system of neonatal rodent upon intracerebral NGF injections. Arch Ital Biol 1978;116:53-84
56. Saffran BN, Woo JE, Mobley WC, et al. Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth. Brain Res 1989;492:245-254
57. Isaacson LG, Saffran BN, Crutcher KA. Intracerebral NGF infusion induces hyperinnervation of cerebral blood vessels. Neurobiol Aging 1990;11:51-55
58. Isaacson LG, Crutcher KA. The duration of sprouted cerebrovascular axons following intracranial infusion of nerve growth factor. Exp Neurol 1995;131:174-179
59. Isaacson LG, Saffran BN, Crutcher KA. Nerve growth factor-induced sprouting of mature, uninjured sympathetic axons. J Comp Neurol 1992;326:327-336
60. Isaacson LG, Ondris D, Crutcher KA. Plasticity of mature sensory cerebrovascular axons following intracranial infusion of nerve growth factor. J Comp Neurol 1995;361:451-460
61. Tuszynski MH, Peterson DA, Ray J, et al. Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp Neurol 1994;126:1-14
62. Verge VMK, Merlio J-P, Grondin J, et al. Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J Neurosci 1992;12:4011-4022
63. Wetmore C, Olson L. Neuronal and nonneuronal expression of neurotrophins and their receptors in sensory and sympathetic ganglia suggest new intracellular trophic interactions. J Comp Neural 1995;353:143-159
64. McMohen SB, Armanini MP, Ling LH, et al. Expression and co-expression of the trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 1994;12:4011-4022
65. Gundersen RW, Barrett JN. Neuronal chemotaxis: chick dorsal-root axons turn toward high concentrations of nerve growth factor. Science 1979;206:1079-1080
66. Ludwin SK, Kosek JC, Eng LF. The topographical distribution of S-100 and GFA proteins in the adult rat brain: an immunohistochemical study using horseradish peroxidase-labelled antibodies. J Comp Neurol 1976;165:197-208
67. Yamaguchi H. Studies on the immunohistochemical localization of S-100 and glial fibrillary acidic proteins in the rat nervous system and in human brain tumors. Brain Nerve 1980;32:1055-1064
68. Autilio-Gambetti L, Sipple J, Sudilovsky O, et al. Intermediate filaments of Schwann cells. J Neurochem 1982;38:774-780
69. Jessen KR, Thorpe R, Mirsky R. Molecular identity, distribution and heterogeneity of glial fibrillary protein: an immunoblotting and immunohistochemical study of Schwann cells, satellite cells, enteric glia and astrocytes. J Neurocytol 1984;13:187-200
70. Jessen KR, Mirsky R. Nonmyelin-forming Schwann cells coexpress surface proteins and intermediate filaments not found in myelin-forming cells: a study of Ran-2, A5E3 antigen and glial fibrillary acidic protein. J Neurocytol 1984;13:923-934
71. Webster HdeF. Development of peripheral nerve fibers. In: Dyck PJ, Thomas PK, Griffin JW, et al, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1993:243-266
72. Fawcett JW, Keynes RJ. Peripheral nerve regeneration. Rev Neurosci 1990;13:43-60
73. Davis JB, Stroobant P. Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells. J Cell Biol 1990;110:1353-1360
74. Raivich G, Kreutzberg GW. Peripheral nerve regeneration: role of growth factors and their receptors. Int J Dev Neurosci 1993;11:311-324
75. Heumann R, Korsching S, Scott J, et al. Changes of NGF synthesis in non-neural cells in response to sciatic nerve transection. J Cell Biol 1987;104:1623-1631
76. Heumann R, Lindholm D, Bandtlow C, et al. Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages. Proc Natl Acad Sci USA 1987;84:8735-8739
77. Sebert ME, Shooter EM. Expression of mRNA for neurotrophic factors and their receptors in the rat dorsal root ganglion and sciatic nerve following nerve injury. J Neurosci Res 1993;36:357-367
78. Funakoshi H, Frisen J, Barbany G, et al Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol 1993;123:455-465
79. Offenhäuser N, Böhm-Matthaei R, Tsouflas P, et al. Developmental regulation of full-length trkC in the rat sciatic nerve. Eur J Neurosci 1995;7:917-925
80. Anton ES, Weskamp G, Reichardt LF, et al. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc Natl Acad Sci USA 1994;91:2795-2799
81. Russell DS, Rubinstein L. Pathology of tumours of the nervous system. London: Edward Arnold Ltd, 1959
82. Adelman LS, Aronson SM. Intramedullary nerve fiber and Schwann cell proliferation within the spinal cord (schwannosis). Neurology 1972;22:726-731
83. Baron-Van Evercooren A, Gansmuller A, Clerin E, et al. Hoechst 33342:a suitable fluorescent marker for Schwann cells after transplantation in the mouse spinal cord. Neurosci Lett 1991;131:241-244
84. 125I] nerve growth factor in the rat brain following an intraventricular injection: sequestration by trkA mRNA expressing septal neurons. Neuroscience 1993;54:445-460
85. Rosenberg MB, Friedmann T, Robertson RC, et al. Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science 1988;242:1575-1578
86. Kawaja MD, Rosenberg MB, Yoshida K, et al. Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J Neurosci 1992;12:2849-2864
87. Dekker AJ, Winkler J, Ray J, et al. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience 1994;60:299-309